Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Hypertension and ABCB11[original query] |
---|
Association of CYP2C9*2 with bosentan-induced liver injury. Clinical pharmacology and therapeutics 2013 Dec 94 (6): 678-86. Markova S M, De Marco T, Bendjilali N, Kobashigawa E A, Mefford J, Sodhi J, Le H, Zhang C, Halladay J, Rettie A E, Khojasteh C, McGlothlin D, Wu A H B, Hsueh W-C, Witte J S, Schwartz J B, Kroetz D |
CYP2C9, SLCO1B1, SLCO1B3, and ABCB11 polymorphisms in patients with bosentan-induced liver toxicity. Clinical pharmacology and therapeutics 2014 Jun 95 (6): 583-5. Roustit M, Fonrose X, Montani D, Girerd B, Stanke-Labesque F, Gonnet N, Humbert M, Cracowski J |
Genetic susceptibility to hepatoxicity due to bosentan treatment in pulmonary hypertension. Annals of hepatology 0 13 (6): 803-9. Seyfarth Hans-Jürgen, Favreau Nadine, Tennert Carsten, Ruffert Claudia, Halank Michael, Wirtz Hubert, Mössner Joachim, Rosendahl Jonas, Kovacs Peter, Wittenburg Henni |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: